Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 August 2023

Sporadic disruptions of academic activities occurred yesterday and this morning on the Bloemfontein, South and Qwaqwa Campuses.

In recent weeks, the university management has made various attempts to keep the campuses open for face-to-face learning and teaching amid challenges experienced with the disbursement of students’ National Student Financial Aid Scheme (NSFAS) allowances through eZaga, an online digital banking service, tasked with dispersing direct payments to NSFAS beneficiaries.

These attempts include, but are not limited to, the attendance of meetings by UFS representatives with NSFAS, arranged by Universities South Africa (USAf); meetings with NSFAS attended by Prof Francis Petersen, Vice-Chancellor and Principal; constant engagements with NSFAS by the university’s Financial Aid Office; a meeting with the Minister of Higher Education, Science and Innovation, Dr Blade Nzimande, to discuss the matter – this was postponed to a later date; constant engagements with the Institutional Student Representative Council (ISRC) on matters relating to NSFAS, etc. These attempts are, however, not acceptable to our students.

To minimise the risk to the academic programme, as well as the fact that this is a sector-wide challenge, the academic programme, (activities, classes, and assignments) will continue online as far as possible from 2 to 4 August 2023. Further information about students’ online academic programme will be communicated by the respective faculties.

The university management would like to thank our academic staff for their commitment during this time, and for ensuring that the academic programme continues through online delivery.

The university is not closed; all other activities will continue as normal.  All campuses are also accessible. The situation on the campuses is being monitored closely and the necessary security measures are in place to ensure the safety of students and staff.

The university’s protocol during protests provides guidance to students and staff on how to act during protests.

Students and staff will be updated on the situation.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept